We are live on ! Find out more
SKBI

SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV)
SKBI

Delisted

SKBI was delisted on the 18th of December, 2015.

Back to rankings

0 hedge funds and large institutions have $0 invested in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in 2016 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $8K → $0 (-$8K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
–
Holders Change
-1
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
California Public Employees Retirement System
California Public Employees Retirement System
California
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
1
California Public Employees Retirement System
California
– -$8K -15,900 Closed

SKBI Hedge Fund Activity: Q1 2016 in Review

0 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) for Q1 2016, worth a combined $0 — down 100% from $8K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SKBI and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was California Public Employees Retirement System, exiting entirely with an estimated $8K sold.

  • 0 institutional investors held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) as of Q1 2016, down from 1 in Q4 2015.
  • Funds reported $0 of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) stock for Q1 2016, down 100% quarter-over-quarter.
  • 0 funds opened new SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) positions in Q1 2016 and 1 closed out, a net change of -1 holder.
  • The largest SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) seller in Q1 2016 was California Public Employees Retirement System, an estimated $8K sold.

Based on aggregated 13F filings for Q1 2016.